Ministry of Industry and Minerals discussed with Russia’s Karas Pharma on Sunday opportunities for cooperation and investment in the pharmaceutical industry.
A statement issued by the ministry said that “the ministry’s adviser for development affairs, Abbas Nasrallah Mahan, discussed with the president of the Russian company Karas Pharma Mr. Elia and the accompanying delegation opportunities for joint cooperation and partnership agreements and investment in the field of pharmaceutical industries in the presence of the general managers in the investment and technical departments in the ministry and the general manager Directorate General for Industrial Development “.
According to the statement, “The General Company for the manufacture of medicines and medical supplies in Samarra has been able to develop a number of plants and production lines to keep abreast of the global development in the pharmaceutical industry.” He expressed the desire of the ministry to reach partnership or investment agreements with international specialized companies, Russian Pharm being established at the same time as the establishment of the Iraqi pharmaceutical company Samarra using technology and production lines similar.
He pointed out that “there are other investment offers offered by European companies to establish a solid lines and laboratories in Samarra pharmaceutical company to cover the need of the local market of medicines and pharmaceuticals produced by the growing domestic demand for it has a reputation and quality and high specification.
Mohann confirmed the keenness of the ministry and its readiness to agree with the Russian company Karas Pharma on the contract and investment in the event of achieving the desired purpose of this contract in the addition of new lines and products and the development of the local pharmaceutical industry, “calling them to” visit the headquarters of the General Company for the manufacture of medicines and medical supplies in Samarra Prelude To submit contract and investment offers for presentation and study. ”
For his part, the president of the Russian company that “his company has seen a great development and added new lines and products, expressing at the same time the desire of his company to transfer the expertise and technology that it owns to pharmaceutical company Samarra to be in the ranks of international companies,” expressing the desire also “to carry out a field visit to the company General Knight to discuss the possibility of working and cooperation with them in the field of heavy industries. “